Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,340,000 | 1,668,000 | 1,541,000 | 1,157,000 | 1,083,000 |
| Receivables | 1,435,000 | 1,388,000 | 1,460,000 | 1,519,000 | 978,000 |
| Inventories | 793,000 | 684,000 | 759,000 | 797,000 | 407,000 |
| Income taxes - deferred | 581,000 | 369,000 | 536,000 | 513,000 | 188,000 |
| Other current assets | 0 | 1,447,000 | 0 | 0 | 0 |
| TOTAL | $4,584,000 | $6,030,000 | $4,749,000 | $4,405,000 | $2,873,000 |
| Non-Current Assets | |||||
| PPE Net | 1,748,000 | 1,644,000 | 1,672,000 | 1,656,000 | 1,024,000 |
| Investments And Advances | 563,000 | 596,000 | 568,000 | 573,000 | 550,000 |
| Intangibles | 23,960,000 | 22,378,000 | 23,543,000 | 23,748,000 | 3,741,000 |
| Other Non-Current Assets | 214,000 | 234,000 | 220,000 | 229,000 | 921,000 |
| TOTAL | $26,485,000 | $24,852,000 | $26,003,000 | $26,206,000 | $6,236,000 |
| Total Assets | $31,069,000 | $30,882,000 | $30,752,000 | $30,611,000 | $9,109,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,000 | 6,000 | 806,000 |
| Accounts payable and accrued liabilities | 1,925,000 | 204,000 | 1,815,000 | 1,509,000 | 1,040,000 |
| Accrued Expenses | N/A | 1,816,000 | N/A | N/A | N/A |
| Other current liabilities | 438,000 | 191,000 | 110,000 | 139,000 | 189,000 |
| TOTAL | $2,370,000 | $2,631,000 | $2,450,000 | $2,173,000 | $2,035,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,898,000 | 8,895,000 | 8,893,000 | 8,892,000 | 1,836,000 |
| Other Non-Current Liabilities | 1,607,000 | 1,488,000 | 1,373,000 | 1,568,000 | 308,000 |
| TOTAL | $13,150,000 | $12,953,000 | $13,286,000 | $13,552,000 | $2,403,000 |
| Total Liabilities | $15,520,000 | $15,584,000 | $15,736,000 | $15,725,000 | $4,438,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,483,198 | 1,480,340 | 1,473,961 | 1,472,440 | 1,463,905 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 8,000 |
| Retained earnings | -80,000 | -174,000 | N/A | N/A | N/A |
| Other shareholders' equity | 50,000 | -1,000 | 15,375,000 | 15,326,000 | 5,336,000 |
| TOTAL | $15,549,000 | $15,298,000 | $15,016,000 | $14,886,000 | $4,671,000 |
| Total Liabilities And Equity | $31,069,000 | $30,882,000 | $30,752,000 | $30,611,000 | $9,109,000 |